{"id":"https://openalex.org/W2105560882","doi":"https://doi.org/10.1158/1535-7163.mct-13-0634","title":"Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways","display_name":"Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways","alternate_titles":[],"publication_year":2014,"publication_date":"2014-06-01","ids":{"openalex":"https://openalex.org/W2105560882","doi":"https://doi.org/10.1158/1535-7163.mct-13-0634","mag":"2105560882","pmid":"https://pubmed.ncbi.nlm.nih.gov/24672057"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-13-0634","doi":"https://doi.org/10.1158/1535-7163.mct-13-0634","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0634","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2105560882"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104110578","display_name":"Khristofer Garcia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Khristofer Garcia","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112007270","display_name":"Jonathan L. Blank","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jonathan L. Blank","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087910135","display_name":"David C. Bouck","orcid":"https://orcid.org/0000-0002-6281-2544","observed_orcids":["https://orcid.org/0000-0002-6281-2544"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David C. Bouck","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036709763","display_name":"Xiaozhen J. Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiaozhen J. Liu","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083836044","display_name":"Darshan S. Sappal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Darshan S. Sappal","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054479296","display_name":"Greg Hather","orcid":"https://orcid.org/0000-0003-3868-8309","observed_orcids":["https://orcid.org/0000-0003-3868-8309"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Greg Hather","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023378022","display_name":"Katherine Cosmopoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katherine Cosmopoulos","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","Pathology, Tufts University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]},{"raw_affiliation_string":"Pathology, Tufts University School of Medicine","institution_ids":["https://openalex.org/I121934306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103509850","display_name":"Michael P. Thomas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael P. Thomas","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063799808","display_name":"Mike Kuranda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mike Kuranda","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049703322","display_name":"Michael D. Pickard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael D. Pickard","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040595816","display_name":"Ray Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ray Liu","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041757055","display_name":"Syamala Bandi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Syamala Bandi","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091086352","display_name":"Peter G. Smith","orcid":"https://orcid.org/0000-0002-1931-7660","observed_orcids":["https://orcid.org/0000-0002-1931-7660"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter G. Smith","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001253562","display_name":"Eric S. Lightcap","orcid":"https://orcid.org/0000-0003-4825-3595","observed_orcids":["https://orcid.org/0000-0003-4825-3595"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Eric S. Lightcap","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Discovery, 2Clinical Biostatistics, and 3Information Technology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5001253562"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3395,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.89719266,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"13","issue":"6","first_page":"1625","last_page":"1635"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mln4924","display_name":"MLN4924","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nedd8-activating-enzyme-inhibitor","display_name":"NEDD8-activating enzyme inhibitor","score":0.9190000295639038},{"id":"https://openalex.org/keywords/mitomycin-c","display_name":"mitomycin C","score":0.9940000176429749},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/re-replication","display_name":"re-replication","score":0.8309999704360962},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.7749999761581421},{"id":"https://openalex.org/keywords/replication-fork-stalling","display_name":"replication fork stalling","score":0.7639999985694885},{"id":"https://openalex.org/keywords/atr-pathway","display_name":"ATR pathway","score":0.9369999766349792},{"id":"https://openalex.org/keywords/brca1-and-brca2","display_name":"BRCA1/BRCA2","score":0.8859999775886536},{"id":"https://openalex.org/keywords/chromatin-dynamics","display_name":"chromatin dynamics","score":0.8399999737739563},{"id":"https://openalex.org/keywords/transcription-coupled-repair","display_name":"transcription-coupled repair","score":0.9229999780654907},{"id":"https://openalex.org/keywords/dna-strand-breaks","display_name":"DNA strand breaks","score":0.8240000009536743},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6700000166893005},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2779338040","wikidata":"https://www.wikidata.org/wiki/Q19856779","display_name":"Mitomycin C","level":2,"score":0.6471915245056152},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.5406038761138916},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.5362147092819214},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.492936372756958},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48625409603118896},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4679155945777893},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4676347076892853},{"id":"https://openalex.org/C73573662","wikidata":"https://www.wikidata.org/wiki/Q130996","display_name":"DNA replication","level":3,"score":0.43956997990608215},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.4094608426094055},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3812166452407837},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3081977665424347},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1977824568748474}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002843","descriptor_name":"Chromatin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002843","descriptor_name":"Chromatin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014466","descriptor_name":"Ultraviolet Rays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016685","descriptor_name":"Mitomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019313","descriptor_name":"BRCA1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019313","descriptor_name":"BRCA1 Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024682","descriptor_name":"BRCA2 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D024682","descriptor_name":"BRCA2 Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044764","descriptor_name":"Ubiquitin-Activating Enzymes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D044764","descriptor_name":"Ubiquitin-Activating Enzymes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064007","descriptor_name":"Ataxia Telangiectasia Mutated Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D064007","descriptor_name":"Ataxia Telangiectasia Mutated Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1535-7163.mct-13-0634","doi":"https://doi.org/10.1158/1535-7163.mct-13-0634","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0634","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:24672057","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24672057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.820.1571","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.820.1571","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/13/6/1625.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.820.9245","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.820.9245","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/early/2014/05/19/1535-7163.MCT-13-0634.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320333965","display_name":"Takeda Pharmaceuticals International","ror":"https://ror.org/002ysmy84"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1970578083","https://openalex.org/W1971348917","https://openalex.org/W1971777367","https://openalex.org/W1973268287","https://openalex.org/W1983584570","https://openalex.org/W1991793156","https://openalex.org/W2004125597","https://openalex.org/W2005833414","https://openalex.org/W2009007206","https://openalex.org/W2012569204","https://openalex.org/W2031189137","https://openalex.org/W2058901070","https://openalex.org/W2061024988","https://openalex.org/W2073770292","https://openalex.org/W2076194625","https://openalex.org/W2085006244","https://openalex.org/W2086333179","https://openalex.org/W2090759699","https://openalex.org/W2091787052","https://openalex.org/W2094887210","https://openalex.org/W2096380982","https://openalex.org/W2096439168","https://openalex.org/W2101248318","https://openalex.org/W2102760949","https://openalex.org/W2108077889","https://openalex.org/W2109519411","https://openalex.org/W2110643123","https://openalex.org/W2121503734","https://openalex.org/W2128546338","https://openalex.org/W2129228724","https://openalex.org/W2131670056","https://openalex.org/W2132215082","https://openalex.org/W2140236604","https://openalex.org/W2143989418","https://openalex.org/W2146217870","https://openalex.org/W2146533600","https://openalex.org/W2149205423","https://openalex.org/W2149795092","https://openalex.org/W2149931676","https://openalex.org/W2335854816"],"related_works":["https://openalex.org/W2103119076","https://openalex.org/W2520260850","https://openalex.org/W1967387100","https://openalex.org/W2566579502","https://openalex.org/W2592821363","https://openalex.org/W4385684698","https://openalex.org/W2085006244","https://openalex.org/W2132215082","https://openalex.org/W2020006740"],"abstract_inverted_index":{"MLN4924":[0,16,73,82,134,155],"is":[1],"an":[2],"investigational":[3],"small-molecule":[4],"inhibitor":[5],"of":[6,29,47,78,95,133,176,187],"the":[7,44,98,114,131,174,184],"Nedd8-activating":[8],"enzyme":[9],"currently":[10],"in":[11,22,70,74,88,157],"phase":[12],"I":[13],"clinical":[14,45,185],"trials.":[15],"induces":[17],"DNA":[18,30,127],"damage":[19,31],"via":[20],"rereplication":[21,152],"most":[23],"cell":[24,164],"lines.":[25],"This":[26,166],"distinct":[27],"mechanism":[28,175],"may":[32,42,179],"affect":[33,43],"its":[34,53],"ability":[35],"to":[36,85,163,172],"combine":[37],"with":[38,55,72,130,151],"standard-of-care":[39],"agents":[40],"and":[41,66,81,101,105,110,119,135],"development":[46,186],"MLN4924.":[48,120],"As":[49],"such,":[50],"we":[51],"studied":[52],"interaction":[54],"other":[56],"DNA-damaging":[57],"agents.":[58],"Mitomycin":[59],"C,":[60],"cisplatin,":[61],"cytarabine,":[62],"UV":[63],"radiation,":[64],"SN-38,":[65],"gemcitabine":[67],"demonstrated":[68,125],"synergy":[69,115],"combination":[71,77,132],"vitro.":[75],"The":[76],"mitomycin":[79,117,136,142],"C":[80,118,143],"was":[83],"shown":[84],"be":[86],"synergistic":[87],"a":[89,169],"mouse":[90],"xenograft":[91],"model.":[92],"Importantly,":[93],"depletion":[94],"genes":[96],"within":[97],"ataxia":[99],"telangiectasia":[100],"Rad3":[102],"related":[103],"(ATR)":[104],"BRCA1/BRCA2":[106],"pathways,":[107],"chromatin":[108],"modification,":[109],"transcription-coupled":[111],"repair":[112],"reduced":[113],"between":[116],"In":[121],"addition,":[122],"comet":[123],"assay":[124],"increased":[126],"strand":[128],"breaks":[129],"C.":[137],"Our":[138],"data":[139],"suggest":[140],"that":[141],"causes":[144],"stalled":[145],"replication":[146,159],"forks,":[147],"which":[148,178],"when":[149],"combined":[150],"induced":[153],"by":[154],"results":[156],"frequent":[158],"fork":[160],"collisions,":[161],"leading":[162],"death.":[165],"study":[167],"provides":[168],"straightforward":[170],"approach":[171],"understand":[173],"synergy,":[177],"provide":[180],"useful":[181],"information":[182],"for":[183],"these":[188],"combinations.":[189]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2105560882","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
